Cornelia Liedtke
The University of Texas MD Anderson Cancer Center(US)University of Münster(DE)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer(2008)2,876 cited
- → Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study(2013)1,433 cited
- → Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer(2009)874 cited
- → Molecular alterations in triple-negative breast cancer—the road to new treatment strategies(2016)858 cited
- → Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer(2011)494 cited
- → T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers(2009)480 cited